{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:14:01Z","timestamp":1778181241681,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["No. Z190013"],"award-info":[{"award-number":["No. Z190013"]}]},{"name":"non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2019PT320026"],"award-info":[{"award-number":["2019PT320026"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 81970205."],"award-info":[{"award-number":["Nos. 81970205."]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long-QT syndrome type 2 (LQT2) is a common malignant hereditary arrhythmia. Due to the lack of suitable animal and human models, the pathogenesis of LQT2 caused by <jats:italic>human ether-a-go-go-related gene<\/jats:italic> (hERG) deficiency is still unclear. In this study, we generated an hERG-deficient human cardiomyocyte (CM) model that simulates \u2018human homozygous hERG mutations\u2019 to explore the underlying impact of hERG dysfunction and the genotype\u2013phenotype relationship of hERG deficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The <jats:italic>KCNH2<\/jats:italic> was knocked out in the human embryonic stem cell (hESC) H9 line using the CRISPR\/Cas9 system. Using a chemically defined differentiation protocol, we obtained and verified hERG-deficient CMs. Subsequently, high-throughput microelectrode array (MEA) assays and drug interventions were performed to characterise the electrophysiological signatures of hERG-deficient cell lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results showed that <jats:italic>KCNH2<\/jats:italic> knockout did not affect the pluripotency or differentiation efficiency of H9 cells. Using high-throughput MEA assays, we found that the electric field potential duration and action potential duration of hERG-deficient CMs were significantly longer than those of normal CMs. The hERG-deficient lines also exhibited irregular rhythm and some early afterdepolarisations. Moreover, we used the hERG-deficient human CM model to evaluate the potency of agents (nifedipine and magnesium chloride) that may ameliorate the phenotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We established an hERG-deficient human CM model that exhibited QT prolongation, irregular rhythm and sensitivity to other ion channel blockers. This model serves as an important tool that can aid in understanding the fundamental impact of hERG dysfunction, elucidate the genotype\u2013phenotype relationship of hERG deficiency and facilitate drug development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02346-1","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T07:03:10Z","timestamp":1620370990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation"],"prefix":"10.1186","volume":"12","author":[{"given":"Yun","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwen","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-4014","authenticated-orcid":false,"given":"Feng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"issue":"8","key":"2346_CR1","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.91.8.3438","volume":"91","author":"J Warmke","year":"1994","unstructured":"Warmke J, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994;91(8):3438\u201342. https:\/\/doi.org\/10.1073\/pnas.91.8.3438.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2346_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","volume":"81","author":"M Sanguinetti","year":"1995","unstructured":"Sanguinetti M, Jiang C, Curran M, Keating M. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81(2):299\u2013307. https:\/\/doi.org\/10.1016\/0092-8674(95)90340-2.","journal-title":"Cell"},{"issue":"2","key":"2346_CR3","first-page":"137","volume":"25","author":"J Cheng","year":"2004","unstructured":"Cheng J, Kodama I. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization. Acta Pharmacol Sin. 2004;25(2):137\u201345.","journal-title":"Acta Pharmacol Sin"},{"key":"2346_CR4","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/ncomms6535","volume":"5","author":"C Anderson","year":"2014","unstructured":"Anderson C, Kuzmicki C, Childs R, Hintz C, Delisle B, January C. Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome. Nature Commun. 2014;5:5535.","journal-title":"Nature Commun"},{"issue":"6","key":"2346_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","volume":"141","author":"A Adler","year":"2020","unstructured":"Adler A, Novelli V, Amin A, Abiusi E, Care M, Nannenberg E, et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation. 2020;141(6):418\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043132.","journal-title":"Circulation"},{"issue":"10","key":"2346_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/europace\/eut272","volume":"15","author":"S Priori","year":"2013","unstructured":"Priori S, Wilde A, Horie M, Cho Y, Behr E, Berul C, et al. Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15(10):1389\u2013406. https:\/\/doi.org\/10.1093\/europace\/eut272.","journal-title":"Europace"},{"issue":"3","key":"2346_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pcad.2019.05.006","volume":"62","author":"M Singh","year":"2019","unstructured":"Singh M, Morin D, Link M. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). Prog Cardiovasc Dis. 2019;62(3):227\u201334. https:\/\/doi.org\/10.1016\/j.pcad.2019.05.006.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"2346_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/17425255.2.1.81","volume":"2","author":"P Stansfeld","year":"2006","unstructured":"Stansfeld P, Sutcliffe M, Mitcheson J. Molecular mechanisms for drug interactions with hERG that cause long QT syndrome. Expert Opin Drug Metab Toxicol. 2006;2(1):81\u201394. https:\/\/doi.org\/10.1517\/17425255.2.1.81.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"2346_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/01.RES.83.6.668","volume":"83","author":"P Babij","year":"1998","unstructured":"Babij P, Askew G, Nieuwenhuijsen B, Su C, Bridal T, Jow B, et al. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circ Res. 1998;83(6):668\u201378. https:\/\/doi.org\/10.1161\/01.RES.83.6.668.","journal-title":"Circ Res"},{"issue":"1","key":"2346_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1113\/jphysiol.2006.118745","volume":"578","author":"G Salama","year":"2007","unstructured":"Salama G, London B. Mouse models of long QT syndrome. J Physiol. 2007;578(1):43\u201353. https:\/\/doi.org\/10.1113\/jphysiol.2006.118745.","journal-title":"J Physiol"},{"issue":"3","key":"2346_CR11","doi-asserted-by":"publisher","first-page":"H1201","DOI":"10.1152\/ajpheart.2001.281.3.H1201","volume":"281","author":"M Brunner","year":"2001","unstructured":"Brunner M, Guo W, Mitchell G, Buckett P, Nerbonne J, Koren G. Characterization of mice with a combined suppression of I(to) and I(K,slow). Am J Physiol Heart Circ Physiol. 2001;281(3):H1201\u20139. https:\/\/doi.org\/10.1152\/ajpheart.2001.281.3.H1201.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"2346_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1085\/jgp.113.5.661","volume":"113","author":"H Xu","year":"1999","unstructured":"Xu H, Guo W, Nerbonne J. Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes. J Gen Physiol. 1999;113(5):661\u201378. https:\/\/doi.org\/10.1085\/jgp.113.5.661.","journal-title":"J Gen Physiol"},{"issue":"3","key":"2346_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00424-007-0436-7","volume":"456","author":"G Liu","year":"2008","unstructured":"Liu G, Zhou J, Koren G. Single-channel properties of I K,slow1 and I K,slow2 in mouse ventricular myocytes. Pflugers Archiv Eur J Physiol. 2008;456(3):541\u20137. https:\/\/doi.org\/10.1007\/s00424-007-0436-7.","journal-title":"Pflugers Archiv Eur J Physiol"},{"issue":"1","key":"2346_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13395-020-00224-7","volume":"10","author":"L Caputo","year":"2020","unstructured":"Caputo L, Granados A, Lenzi J, Rosa A, Ait-Si-Ali S, Puri P, et al. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGF\u03b2-dependent pro-fibrotic signaling. Skeletal Muscle. 2020;10(1):13. https:\/\/doi.org\/10.1186\/s13395-020-00224-7.","journal-title":"Skeletal Muscle"},{"issue":"1","key":"2346_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","volume":"12","author":"F Lan","year":"2013","unstructured":"Lan F, Lee A, Liang P, Sanchez-Freire V, Nguyen P, Wang L, et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013;12(1):101\u201313. https:\/\/doi.org\/10.1016\/j.stem.2012.10.010.","journal-title":"Cell Stem Cell"},{"key":"2346_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/stem.2450","volume":"35","author":"D Ilic","year":"2017","unstructured":"Ilic D, Ogilvie C. Concise review: human embryonic stem cells-what have we done? What are we doing? Where are we going? Stem cells (Dayton, Ohio). 2017;35:17\u201325.","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"7","key":"2346_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.4103\/0366-6999.228231","volume":"131","author":"F Wang","year":"2018","unstructured":"Wang F, Kong J, Cui Y, Liu P, Wen J. Is Human-induced Pluripotent Stem Cell the Best Optimal? Chin Med J (Engl). 2018;131(7):852\u20136. https:\/\/doi.org\/10.4103\/0366-6999.228231.","journal-title":"Chin Med J (Engl)"},{"key":"2346_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.gde.2017.07.004","volume":"46","author":"D Ortmann","year":"2017","unstructured":"Ortmann D, Vallier L. Variability of human pluripotent stem cell lines. Curr Opin Genet Dev. 2017;46:179\u201385. https:\/\/doi.org\/10.1016\/j.gde.2017.07.004.","journal-title":"Curr Opin Genet Dev"},{"issue":"7337","key":"2346_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","volume":"471","author":"I Itzhaki","year":"2011","unstructured":"Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471(7337):225\u20139. https:\/\/doi.org\/10.1038\/nature09747.","journal-title":"Nature"},{"issue":"5","key":"2346_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jacc.2014.04.057","volume":"64","author":"Y Wang","year":"2014","unstructured":"Wang Y, Liang P, Lan F, Wu H, Lisowski L, Gu M, et al. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. J Am Coll Cardiol. 2014;64(5):451\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.057.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2346_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacc.2018.04.041","volume":"72","author":"P Garg","year":"2018","unstructured":"Garg P, Oikonomopoulos A, Chen H, Li Y, Lam C, Sallam K, et al. Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. J Am Coll Cardiol. 2018;72(1):62\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.041.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2346_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.stemcr.2020.10.005","volume":"15","author":"K Brand\u00e3o","year":"2020","unstructured":"Brand\u00e3o K, van den Brink L, Miller D, Grandela C, van Meer B, Mol M, et al. Isogenic sets of hiPSC-CMs harboring distinct KCNH2 mutations differ functionally and in susceptibility to drug-induced arrhythmias. Stem Cell Reports. 2020;15(5):1127\u201339. https:\/\/doi.org\/10.1016\/j.stemcr.2020.10.005.","journal-title":"Stem Cell Reports"},{"key":"2346_CR23","doi-asserted-by":"publisher","unstructured":"Shah D, Prajapati C, Penttinen K, Cherian R, Koivum\u00e4ki J, Alexanova A, Hyttinen J, Aalto-Set\u00e4l\u00e4 K. hiPSC-derived cardiomyocyte model of LQT2 syndrome derived from asymptomatic and symptomatic mutation carriers reproduces clinical differences in aggregates but not in single cells. Cells. 2020;9(5):1153. https:\/\/doi.org\/10.3390\/cells9051153.","DOI":"10.3390\/cells9051153"},{"key":"2346_CR24","doi-asserted-by":"publisher","first-page":"590581","DOI":"10.3389\/fcell.2020.590581","volume":"8","author":"T Qi","year":"2020","unstructured":"Qi T, Wu F, Xie Y, Gao S, Li M, Pu J, et al. Base editing mediated generation of point mutations into human pluripotent stem cells for modeling disease. Front Cell Dev Biol. 2020;8:590581. https:\/\/doi.org\/10.3389\/fcell.2020.590581.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2346_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stemcr.2019.06.007","volume":"13","author":"D Yoshinaga","year":"2019","unstructured":"Yoshinaga D, Baba S, Makiyama T, Shibata H, Hirata T, Akagi K, et al. Phenotype-based high-throughput classification of long QT syndrome subtypes using human induced pluripotent stem cells. Stem Cell Reports. 2019;13(2):394\u2013404. https:\/\/doi.org\/10.1016\/j.stemcr.2019.06.007.","journal-title":"Stem Cell Reports"},{"issue":"4","key":"2346_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/07853890600756065","volume":"38","author":"H Fodstad","year":"2006","unstructured":"Fodstad H, Bendahhou S, Rougier J, Laitinen-Forsblom P, Barhanin J, Abriel H, et al. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients. Ann Med. 2006;38(4):294\u2013304. https:\/\/doi.org\/10.1080\/07853890600756065.","journal-title":"Ann Med"},{"issue":"2","key":"2346_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1242\/dmm.008409","volume":"5","author":"A Lahti","year":"2012","unstructured":"Lahti A, Kujala V, Chapman H, Koivisto A, Pekkanen-Mattila M, Kerkel\u00e4 E, et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech. 2012;5(2):220\u201330. https:\/\/doi.org\/10.1242\/dmm.008409.","journal-title":"Dis Model Mech"},{"issue":"8","key":"2346_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"P Burridge","year":"2014","unstructured":"Burridge P, Matsa E, Shukla P, Lin Z, Churko J, Ebert A, et al. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11(8):855\u201360. https:\/\/doi.org\/10.1038\/nmeth.2999.","journal-title":"Nat Methods"},{"issue":"1","key":"2346_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","volume":"12","author":"S Tohyama","year":"2013","unstructured":"Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2013;12(1):127\u201337. https:\/\/doi.org\/10.1016\/j.stem.2012.09.013.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2346_CR30","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s41598-017-02456-y","volume":"7","author":"Y Xie","year":"2017","unstructured":"Xie Y, Wang D, Lan F, Wei G, Ni T, Chai R, et al. An episomal vector-based CRISPR\/Cas9 system for highly efficient gene knockout in human pluripotent stem cells. Sci Rep. 2017;7(1):2320. https:\/\/doi.org\/10.1038\/s41598-017-02456-y.","journal-title":"Sci Rep"},{"issue":"24","key":"2346_CR31","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/emboj.2013.240","volume":"32","author":"M Bellin","year":"2013","unstructured":"Bellin M, Casini S, Davis R, D'Aniello C, Haas J, Ward-van Oostwaard D, et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J. 2013;32(24):3161\u201375. https:\/\/doi.org\/10.1038\/emboj.2013.240.","journal-title":"EMBO J"},{"key":"2346_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002159","volume":"4","author":"M Jouni","year":"2015","unstructured":"Jouni M, Si-Tayeb K, Es-Salah-Lamoureux Z, Latypova X, Champon B, Caillaud A, et al. Toward personalized medicine: using cardiomyocytes differentiated from urine-derived pluripotent stem cells to recapitulate electrophysiological characteristics of type 2 long QT syndrome. J Am Heart Assoc. 2015;4:e002159.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2346_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jemt.23021","volume":"81","author":"G Cheng","year":"2018","unstructured":"Cheng G, Wu J, Han W, Sun C. F463L increases the potential of dofetilide on human ether-a-go-go-related gene (hERG) channels. Microsc Res Tech. 2018;81(6):663\u20138. https:\/\/doi.org\/10.1002\/jemt.23021.","journal-title":"Microsc Res Tech"},{"issue":"12","key":"2346_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tips.2003.10.002","volume":"24","author":"L Belardinelli","year":"2003","unstructured":"Belardinelli L, Antzelevitch C, Vos M. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci. 2003;24(12):619\u201325. https:\/\/doi.org\/10.1016\/j.tips.2003.10.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2346_CR35","doi-asserted-by":"publisher","first-page":"11893","DOI":"10.1038\/s41598-019-48174-5","volume":"9","author":"H Hayes","year":"2019","unstructured":"Hayes H, Nicolini A, Arrowood C, Chvatal S, Wolfson D, Cho H, et al. Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology. Sci Rep. 2019;9(1):11893. https:\/\/doi.org\/10.1038\/s41598-019-48174-5.","journal-title":"Sci Rep"},{"issue":"6868","key":"2346_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/415213a","volume":"415","author":"E Marb\u00e1n","year":"2002","unstructured":"Marb\u00e1n E. Cardiac channelopathies. Nature. 2002;415(6868):213\u20138. https:\/\/doi.org\/10.1038\/415213a.","journal-title":"Nature"},{"issue":"11_suppl_1","key":"2346_CR37","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1161\/CIRCULATIONAHA.112.000570","volume":"128","author":"E Navarrete","year":"2013","unstructured":"Navarrete E, Liang P, Lan F, Sanchez-Freire V, Simmons C, Gong T, et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation. 2013;128(11_suppl_1):S3\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000570.","journal-title":"Circulation"},{"key":"2346_CR38","doi-asserted-by":"publisher","unstructured":"Ono M, Burgess D, Schroder E, Elayi C, Anderson C, January C, et al. Long QT Syndrome type 2: emerging strategies for correcting class 2 KCNH2 (hERG) mutations and identifying new patients. Biomolecules. 2020;10(8). https:\/\/doi.org\/10.3390\/biom10081144.","DOI":"10.3390\/biom10081144"},{"issue":"3","key":"2346_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","volume":"61","author":"S Peng","year":"2010","unstructured":"Peng S, Lacerda A, Kirsch G, Brown A, Bruening-Wright A. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J Pharmacol Toxicol Methods. 2010;61(3):277\u201386. https:\/\/doi.org\/10.1016\/j.vascn.2010.01.014.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"5","key":"2346_CR40","doi-asserted-by":"publisher","first-page":"497S","DOI":"10.1080\/07315724.2004.10719388","volume":"23","author":"K Hoshino","year":"2004","unstructured":"Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y. Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome. J Am Coll Nutr. 2004;23(5):497S\u2013500S. https:\/\/doi.org\/10.1080\/07315724.2004.10719388.","journal-title":"J Am Coll Nutr"},{"issue":"12","key":"2346_CR41","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1161\/01.CIR.100.12.1264","volume":"100","author":"T Hoorntje","year":"1999","unstructured":"Hoorntje T, Alders M, van Tintelen P, van der Lip K, Sreeram N, van der Wal A, et al. Homozygous premature truncation of the HERG protein : the human HERG knockout. Circulation. 1999;100(12):1264\u20137. https:\/\/doi.org\/10.1161\/01.CIR.100.12.1264.","journal-title":"Circulation"},{"issue":"5","key":"2346_CR42","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1203\/01.PDR.0000059750.17002.B6","volume":"53","author":"W Johnson","year":"2003","unstructured":"Johnson W, Yang P, Yang T, Lau Y, Mostella B, Wolff D, et al. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res. 2003;53(5):744\u20138. https:\/\/doi.org\/10.1203\/01.PDR.0000059750.17002.B6.","journal-title":"Pediatr Res"},{"issue":"7","key":"2346_CR43","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0735-1097(00)00636-7","volume":"35","author":"K Piippo","year":"2000","unstructured":"Piippo K, Laitinen P, Swan H, Toivonen L, Viitasalo M, Pasternack M, et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol. 2000;35(7):1919\u201325. https:\/\/doi.org\/10.1016\/S0735-1097(00)00636-7.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2346_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1152\/physrev.00008.2016","volume":"97","author":"M Bohnen","year":"2017","unstructured":"Bohnen M, Peng G, Robey S, Terrenoire C, Iyer V, Sampson K, et al. Molecular pathophysiology of congenital long QT syndrome. Physiol Rev. 2017;97(1):89\u2013134. https:\/\/doi.org\/10.1152\/physrev.00008.2016.","journal-title":"Physiol Rev"},{"issue":"2","key":"2346_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.2011.01558.x","volume":"165","author":"L Nalos","year":"2012","unstructured":"Nalos L, Varkevisser R, Jonsson M, Houtman M, Beekman J, van der Nagel R, et al. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes. Br J Pharmacol. 2012;165(2):467\u201378. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01558.x.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2346_CR46","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1113\/JP272883","volume":"595","author":"N Chiamvimonvat","year":"2017","unstructured":"Chiamvimonvat N, Chen-Izu Y, Clancy C, Deschenes I, Dobrev D, Heijman J, et al. Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics. J Physiol. 2017;595(7):2229\u201352. https:\/\/doi.org\/10.1113\/JP272883.","journal-title":"J Physiol"},{"key":"2346_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2015.08.010","volume":"31","author":"P Damdimopoulou","year":"2016","unstructured":"Damdimopoulou P, Rodin S, Stenfelt S, Antonsson L, Tryggvason K, Hovatta O. Human embryonic stem cells. Best practice & research. Clin Obstet Gynaecol. 2016;31:2\u201312. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.08.010.","journal-title":"Clin Obstet Gynaecol"},{"key":"2346_CR48","doi-asserted-by":"publisher","first-page":"20140367","DOI":"10.1098\/rstb.2014.0367","volume":"370","author":"M Ohnuki","year":"2015","unstructured":"Ohnuki M, Takahashi K. Present and future challenges of induced pluripotent stem cells. Philosophical transactions of the Royal Society of London. Series B, Biol Sci. 2015;370:20140367.","journal-title":"Series B, Biol Sci"},{"issue":"5","key":"2346_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/070674371506000502","volume":"60","author":"S Rabkin","year":"2015","unstructured":"Rabkin S. Impact of Age and Sex on QT Prolongation in patients receiving psychotropics. Canadian journal of psychiatry. Revue Canadienne de Psychiatrie. 2015;60(5):206\u201314. https:\/\/doi.org\/10.1177\/070674371506000502.","journal-title":"Revue Canadienne de Psychiatrie"},{"key":"2346_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1634\/stemcells.2006-0466","volume":"25","author":"L Sartiani","year":"2007","unstructured":"Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi M. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells (Dayton, Ohio). 2007;25:1136\u201344.","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"25","key":"2346_CR51","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1161\/CIRCULATIONAHA.120.048916","volume":"142","author":"F Dagradi","year":"2020","unstructured":"Dagradi F, Spazzolini C, Castelletti S, Pedrazzini M, Kotta M, Crotti L, et al. Exercise training-induced repolarization abnormalities masquerading as congenital long QT syndrome. Circulation. 2020;142(25):2405\u201315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048916.","journal-title":"Circulation"},{"issue":"13","key":"2346_CR52","doi-asserted-by":"publisher","first-page":"9874","DOI":"10.1074\/jbc.M610875200","volume":"282","author":"P Phartiyal","year":"2007","unstructured":"Phartiyal P, Jones E, Robertson G. Heteromeric assembly of human ether-\u00e0-go-go-related gene (hERG) 1a\/1b channels occurs cotranslationally via N-terminal interactions. J Biol Chem. 2007;282(13):9874\u201382. https:\/\/doi.org\/10.1074\/jbc.M610875200.","journal-title":"J Biol Chem"},{"issue":"3","key":"2346_CR53","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0002-8703(89)90258-5","volume":"118","author":"S Kaseda","year":"1989","unstructured":"Kaseda S, Gilmour R, Zipes D. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers. Am Heart J. 1989;118(3):458\u201366. https:\/\/doi.org\/10.1016\/0002-8703(89)90258-5.","journal-title":"Am Heart J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02346-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T07:16:57Z","timestamp":1620371817000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02346-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02346-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}